封锁
免疫检查点
签名(拓扑)
免疫疗法
计算机科学
肿瘤科
医学
计算生物学
免疫系统
免疫学
生物
内科学
数学
受体
几何学
作者
Nan Zhang,Mei Yang,Jing‐Min Yang,C. Zhang,An‐Yuan Guo
标识
DOI:10.1002/smtd.202301685
摘要
Abstract Immune checkpoint blockade (ICB) therapy has brought significant advancements to the field of oncology. However, the diverse responses among patients highlight the need for more accurate predictive tools. In this study, insights are drawn from tumor‐immunology pathways, and a novel network‐based ICB immunotherapeutic signature, termed ICBnetIS, is constructed. The signature is derived from advanced biological network‐based computational strategies involving co‐expression networks and molecular interactions networks. The efficacy of ICBnetIS is established through its association with enhanced patient survival and a robust immune response characterized by diverse immune cell infiltration and active anti‐tumor immune pathways. The validation process positions ICBnetIS as an effective tool in predicting responses to ICB therapy, analyzing ICB data from a broad collection of over 700 samples from multiple cancer types of more than 15 datasets. It achieves an aggregated prediction AUC of 0.784, which outperforms the other nine renowned immunotherapeutic signatures, indicating the superior predictive capability of ICBnetIS. To sum up, the findings suggest ICBnetIS as a potent tool in predicting ICB therapy responses, offering significant implications for patient selection and treatment optimization in oncology. The study highlights the role of ICBnetIS in advancing personalized treatment strategies, potentially transforming the clinical landscape of ICB therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI